SCHEMBL2846340

SCHEMBL2846340

Cc1ccccc1-n1nnnc1C(Cl)(Cl)C(=O)Nc1ccncc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYK2 P29597 2/20 0.42
ALDH1A1 P00352 7/20 0.41
TSHR P16473 1/20 0.40
HSD11B1 P28845 1/20 0.40
KMT2A Q03164 4/20 0.39
MAPK13 O15264 1/20 0.39
MAPK12 P53778 1/20 0.39
MAPK11 Q15759 1/20 0.39
MAPK14 Q16539 1/20 0.39
LMNA P02545 3/20 0.38
MAPT P10636 2/20 0.38
MEN1 O00255 2/20 0.38
FLT3 P36888 1/20 0.38
GSK3B P49841 1/20 0.38
KDM4E B2RXH2 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
TAAR1 Q96RJ0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2855140 0.92 ALDH1A1 (0.46) ALDH1A1TSHRHSD11B1KMT2AMAPK13
SCHEMBL13354145 0.90 TYK2 (0.41) TYK2ALDH1A1TSHRHSD11B1KMT2A
SCHEMBL2851627 0.81 ALDH1A1 (0.43) ALDH1A1TSHRHSD11B1KMT2ALMNA
SCHEMBL13354144 0.79 MAPK13 (0.49) ALDH1A1TSHRHSD11B1KMT2AMAPK13
SCHEMBL2843430 0.78 ALDH1A1 (0.53) ALDH1A1TSHRHSD11B1KMT2AMAPK14
SCHEMBL2846682 0.76 ALDH1A1 (0.46) ALDH1A1TSHRHSD11B1KMT2ALMNA
SCHEMBL2853837 0.76 ALDH1A1 (0.57) ALDH1A1KMT2ALMNAMAPTMEN1
SCHEMBL2851117 0.74 ALDH1A1 (0.40) ALDH1A1TSHRHSD11B1KMT2ALMNA
SCHEMBL2008495 0.73 ALDH1A1 (0.60) ALDH1A1TSHRHSD11B1LMNAMAPT
SCHEMBL13354146 0.72 ALDH1A1 (0.52) ALDH1A1TSHRHSD11B1KMT2AMAPK13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100130509-A1 NOVEL ANTIBIOTICS NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWE- TENSCHAPPELIJK ONDERZOEK TNO (NL) 2010-05-27 US disclosed
EP-2139872-A1 NOVEL ANTIBIOTICS Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO (NL) 2010-01-06 EP disclosed
WO-2008120992-A1 NOVEL ANTIBIOTICS NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) 2008-10-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130509-A1 NOVEL ANTIBIOTICS TMEM165, LAS1L, RPS2 TYK2 3343/4885ALDH1A1 4431/4885TSHR 3686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.